Agitation in Dementia Can Be Helped by Medical Cannabis, Study Suggests
A new study suggests medical cannabis can reduce agitation and confusion in patients with late-stage dementia.
Quick answers
Who specifically benefited from the treatment in the trial?
The trial found that cannabis-derived treatment helped hospice-eligible dementia patients and those with late-stage Alzheimer's.
What specific compounds were mentioned as promising?
Coverage identifies THC and CBD as showing promise for treating agitation.
What symptoms did the cannabis treatment address?
The treatment was shown to ease confusion and agitation.
The brief
Recent trial results indicate that cannabis-derived treatments may ease agitation in dementia patients, specifically those who are hospice-eligible. These findings suggest that a combination of THC and CBD shows promise for treating symptoms in late-stage Alzheimer’s.
Coverage from The New York Times, Medical Xpress, The Sun, and Being Patient emphasizes the effectiveness of the treatment in calming confused patients. The reports focus on the trial's application within specific patient demographics, such as those in late-stage disease progression.
Future attention will likely center on the broader application of these THC/CBD treatments for dementia-related agitation as the study's findings are further analyzed.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 46d ago.
Sources (8)
- MediPharm Labs Announces Positive Phase II LiBBY Trial Results Demonstrating Significant Reduction in Agitation Associated With Advanced Alzheimer’s Disease and Dementia Toronto Star · 45d ago
- Cannabis Combo Eases Agitation From Dementia Newser · 45d ago
- MediPharm Labs Announces Positive Phase II LiBBY Trial Results Demonstrating Significant Reduction in Agitation Associated With Advanced Alzheimer’s Disease and Dementia markets.businessinsider.com · 46d ago
- Nine out of 10 elderly dementia sufferers become less agitated after marijuana treatment, study finds The Independent · 46d ago
- Cannabis shown to ease confused and agitated dementia patients in trial The Sun · 46d ago
- THC/CBD Shows Promise for Treating Agitation in Late-Stage Alzheimer’s Being Patient · 46d ago
- Cannabis-derived treatment eases agitation in hospice-eligible dementia patients, trial finds Medical Xpress · 46d ago
- Agitation in Dementia Can Be Helped by Medical Cannabis, Study Suggests The New York Times · 46d ago broke it first
How fast it spread
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
People, places & organizations
Topics
Related trends
FDA Approves Alzheimer’s Blood Test Developed by Roche and Eli Lilly
The FDA has granted clearance to a new Alzheimer’s disease blood test developed by Roche and Eli Lilly.
Blood Tests to Predict Alzheimer’s Are Causing Confusion and Distress
A breakthrough blood test promises earlier Alzheimer’s diagnosis, yet patients grapple with rising confusion and distress.
UK doctors say breakthrough in Alzheimer’s research may have found way to restore sleep
UK doctors find potential breakthrough in Alzheimer's research linked to sleep restoration
A hidden Alzheimer’s tipping point may decide who gets dementia
Midlife brain remodeling may set a hidden tipping point that determines who later develops Alzheimer’s.
Neurologists see these 8 brain health mistakes almost every day, and many people don't realise they're making them
Neurologists are warning against common brain health mistakes, with a strong focus on the critical role of quality sleep in cognitive preservation.
Rapid Review Quiz: Evidence-Based Prevention of Dementia
New WHO guidelines suggest up to 45% of dementia risk could be prevented or delayed through evidence-based interventions.